Macrophage Polarisation Changes Within the Time Between Diagnostic Biopsy and Tumour Resection in Oral Squamous Cell Carcinomas--an Immunohistochemical Study

Overview

Journal Br J Cancer

Specialty Oncology

Date 2015 Jun 26

PMID 26110975

Citations 41

Authors

M Weber

P Moebius

M Buttner-Herold

K Amann

R Preidl

F W Neukam

F Wehrhan

Affiliations

Soon will be listed here.

Abstract

Background: The prognosis of solid malignancies has been shown to depend on immunological parameters, such as macrophage polarisation (M1/M2). Recently, it was reported that preoperative oral surgery leads to a worsening of oral squamous cell carcinomas (OSCC) prognosis. Diagnostic incision biopsies are oral surgery procedures that might lead to healing-associated M2 macrophage polarisation with a potential negative influence on tumour biology. No studies have compared macrophage polarisation in OSCC biopsies and tumour specimens.

Methods: Preoperative diagnostic incision biopsies (n=25) and tumour resection specimens (n=34) of T1/T2 OSCC were processed for immunohistochemistry to detect CD68-, CD11c-, CD163- and MRC1-positive cells. Samples were digitised using whole-slide imaging, and the expression of macrophage markers was quantitatively analysed.

Results: Carcinoma tissues obtained during OSCC tumour resections showed a significantly (P<0.05) increased CD163 cell count (M2 macrophages) compared with tissues obtained during preoperative incision biopsies. Additionally, the CD163/CD68 ratio (an indicator of M2 polarisation) was significantly (P<0.05) higher in tumour resection specimens than in biopsies.

Conclusions: This study revealed for the first time an increase in M2 polarisation in samples obtained during OSCC tumour resection surgery compared with preoperative incision biopsies. The biopsy-induced tissue trauma might explain the observed shift in macrophage polarisation towards the tumour-promoting M2 type and could lead to accelerated tumour progression.

Citing Articles

Dendritic cell effector mechanisms and tumor immune microenvironment infiltration define TLR8 modulation and PD-1 blockade.

Ruiz-Torres D, Wise J, Zhao B, Oliveira-Costa J, Cavallaro S, Sadow P Front Immunol. 2024; 15():1440530.

PMID: 39697344 PMC: 11652363. DOI: 10.3389/fimmu.2024.1440530.

Defining intra-tumoral and systemic immune biomarkers for locally advanced head-and-neck cancer - detailed protocol of a prospective, observatory multicenter trial (ImmunBioKHT) and first results of the immunophenotyping of the patients' peripheral....

Donaubauer A, Frey B, Weber M, Allner M, Vogl C, Almajali O Front Oncol. 2024; 14:1451035.

PMID: 39346733 PMC: 11427411. DOI: 10.3389/fonc.2024.1451035.

Comparative Analysis of Inhibitory and Activating Immune Checkpoints PD-1, PD-L1, CD28, and CD86 in Non-Melanoma Skin Cancer.

Winter L, Ries J, Vogl C, Trumet L, Geppert C, Lutz R Cells. 2024; 13(18.

PMID: 39329753 PMC: 11430031. DOI: 10.3390/cells13181569.

Dendritic cell effector mechanisms and tumor immune microenvironment infiltration define TLR8 modulation and PD-1 blockade.

Ruiz-Torres D, Wise J, Zhao B, Oliveira-Costa J, Cavallaro S, Sadow P bioRxiv. 2024; .

PMID: 39282367 PMC: 11398323. DOI: 10.1101/2024.09.03.610636.

Minimally invasive biopsy-based diagnostics in support of precision cancer medicine.

Franzen B, Auer G, Lewensohn R Mol Oncol. 2024; 18(11):2612-2628.

PMID: 38519839 PMC: 11547246. DOI: 10.1002/1878-0261.13640.

References

Klug F, Prakash H, Huber P, Seibel T, Bender N, Halama N . Low-dose irradiation programs macrophage differentiation to an iNOS⁺/M1 phenotype that orchestrates effective T cell immunotherapy. Cancer Cell. 2013; 24(5):589-602. DOI: 10.1016/j.ccr.2013.09.014. View

Barros M, Hauck F, Dreyer J, Kempkes B, Niedobitek G . Macrophage polarisation: an immunohistochemical approach for identifying M1 and M2 macrophages. PLoS One. 2013; 8(11):e80908. PMC: 3829941. DOI: 10.1371/journal.pone.0080908. View

Rubner Y, Muth C, Strnad A, Derer A, Sieber R, Buslei R . Fractionated radiotherapy is the main stimulus for the induction of cell death and of Hsp70 release of p53 mutated glioblastoma cell lines. Radiat Oncol. 2014; 9(1):89. PMC: 3994240. DOI: 10.1186/1748-717X-9-89. View

Buenrostro D, Park S, Sterling J . Dissecting the role of bone marrow stromal cells on bone metastases. Biomed Res Int. 2014; 2014:875305. PMC: 4099112. DOI: 10.1155/2014/875305. View

Wehrhan F, Buttner-Herold M, Hyckel P, Moebius P, Preidl R, Distel L . Increased malignancy of oral squamous cell carcinomas (oscc) is associated with macrophage polarization in regional lymph nodes - an immunohistochemical study. BMC Cancer. 2014; 14:522. PMC: 4223559. DOI: 10.1186/1471-2407-14-522. View

Mantovani A, Vecchi A, Allavena P . Pharmacological modulation of monocytes and macrophages. Curr Opin Pharmacol. 2014; 17:38-44. DOI: 10.1016/j.coph.2014.07.004. View

Kulzer L, Rubner Y, Deloch L, Allgauer A, Frey B, Fietkau R . Norm- and hypo-fractionated radiotherapy is capable of activating human dendritic cells. J Immunotoxicol. 2014; 11(4):328-36. DOI: 10.3109/1547691X.2014.880533. View

Balermpas P, Rodel F, Liberz R, Oppermann J, Wagenblast J, Ghanaati S . Head and neck cancer relapse after chemoradiotherapy correlates with CD163+ macrophages in primary tumour and CD11b+ myeloid cells in recurrences. Br J Cancer. 2014; 111(8):1509-18. PMC: 4200089. DOI: 10.1038/bjc.2014.446. View

Kumar V, Gabrilovich D . Hypoxia-inducible factors in regulation of immune responses in tumour microenvironment. Immunology. 2014; 143(4):512-9. PMC: 4253499. DOI: 10.1111/imm.12380. View

10.

Weber M, Buttner-Herold M, Hyckel P, Moebius P, Distel L, Ries J . Small oral squamous cell carcinomas with nodal lymphogenic metastasis show increased infiltration of M2 polarized macrophages--an immunohistochemical analysis. J Craniomaxillofac Surg. 2014; 42(7):1087-94. DOI: 10.1016/j.jcms.2014.01.035. View

11.

Fischer-Posovszky P, Wang Q, Asterholm I, Rutkowski J, Scherer P . Targeted deletion of adipocytes by apoptosis leads to adipose tissue recruitment of alternatively activated M2 macrophages. Endocrinology. 2011; 152(8):3074-81. PMC: 3138241. DOI: 10.1210/en.2011-1031. View

12.

Cao X, Shen D, Patel M, Tuo J, Johnson T, Olsen T . Macrophage polarization in the maculae of age-related macular degeneration: a pilot study. Pathol Int. 2011; 61(9):528-35. PMC: 3292787. DOI: 10.1111/j.1440-1827.2011.02695.x. View

13.

Rogers T, Holen I . Tumour macrophages as potential targets of bisphosphonates. J Transl Med. 2011; 9:177. PMC: 3215187. DOI: 10.1186/1479-5876-9-177. View

14.

Sica A, Mantovani A . Macrophage plasticity and polarization: in vivo veritas. J Clin Invest. 2012; 122(3):787-95. PMC: 3287223. DOI: 10.1172/JCI59643. View

15.

Anzai A, Anzai T, Nagai S, Maekawa Y, Naito K, Kaneko H . Regulatory role of dendritic cells in postinfarction healing and left ventricular remodeling. Circulation. 2012; 125(10):1234-45. DOI: 10.1161/CIRCULATIONAHA.111.052126. View

16.

Hao N, Lu M, Fan Y, Cao Y, Zhang Z, Yang S . Macrophages in tumor microenvironments and the progression of tumors. Clin Dev Immunol. 2012; 2012:948098. PMC: 3385963. DOI: 10.1155/2012/948098. View

17.

Hasan D, Chalouhi N, Jabbour P, Hashimoto T . Macrophage imbalance (M1 vs. M2) and upregulation of mast cells in wall of ruptured human cerebral aneurysms: preliminary results. J Neuroinflammation. 2012; 9:222. PMC: 3488554. DOI: 10.1186/1742-2094-9-222. View

18.

Mantovani A, Biswas S, Galdiero M, Sica A, Locati M . Macrophage plasticity and polarization in tissue repair and remodelling. J Pathol. 2012; 229(2):176-85. DOI: 10.1002/path.4133. View

19.

Herwig M, Bergstrom C, Wells J, Holler T, Grossniklaus H . M2/M1 ratio of tumor associated macrophages and PPAR-gamma expression in uveal melanomas with class 1 and class 2 molecular profiles. Exp Eye Res. 2012; 107:52-8. PMC: 3556238. DOI: 10.1016/j.exer.2012.11.012. View

20.

Takahashi H, Umeda M, Takahashi Y, Matsui T, Shigeta T, Minamikawa T . Influence of preoperative dental procedures on the prognosis of patients with squamous cell carcinoma of the gingiva. Br J Oral Maxillofac Surg. 2012; 51(2):108-12. DOI: 10.1016/j.bjoms.2012.05.006. View